VistaGen Therapeutics Reports Third Quarter Fiscal 2018 Financial Results - Marketwired (press release)

VistaGen Therapeutics Reports Third Quarter Fiscal 2018 Financial ResultsMarketwired (press release)"Building on our significant progress last quarter, our team is prepared and eager to launch, during the current quarter, our AV-101 Phase 2 clinical development program, initially focused on adjunctive treatment of Major Depressive Disorder patients ...